Computed tomography is the first-line imaging modality for suspected pancreatic cancer. Magnetic resonance cholangiopancreatography is a second-line modality for suspected …
S Li, W Zhang, R Xing, C Yuan, H Xue… - Advanced …, 2021 - Wiley Online Library
Pancreatic cancer, one of the most lethal malignancies, compromises the performance of traditional therapeutic regimens in the clinic because of stromal resistance to systemic drug …
Pancreatic cancer is a major cause of cancer-associated mortality, with a dismal overall prognosis that has remained virtually unchanged for many decades. Currently, prevention or …
M Erkan, S Hausmann, CW Michalski… - Nature reviews …, 2012 - nature.com
Pancreatic ductal adenocarcinoma (PDAC) is one of the five most lethal malignancies worldwide and survival has not improved substantially in the past 30 years. Desmoplasia …
R Liu, X Li, W Xiao, KS Lam - Advanced drug delivery reviews, 2017 - Elsevier
Cancer is one of the major and leading causes of death worldwide. Two of the greatest challenges in fighting cancer are early detection and effective treatments with no or …
BP Gray, KC Brown - Chemical reviews, 2014 - ACS Publications
The surface of a cell represents a collection of macromolecules, which provides the cell with a unique cellular landscape specific to the type and state of the cell. Ligands that …
GY Liou, H Döppler, B Necela, B Edenfield, L Zhang… - Cancer discovery, 2015 - AACR
Desmoplasia and an inflammatory environment are defining features of pancreatic cancer. Unclear is how pancreatic cells that undergo oncogenic transformation can cross-talk with …
W Sun, Y Ren, Z Lu, X Zhao - Molecular cancer, 2020 - Springer
Pancreatic cancer (PaCa) is an insidious and highly metastatic malignancy, with a 5-year survival rate of less than 5%. So far, the pathogenesis and progression mechanisms of …
N Sturm, TJ Ettrich, L Perkhofer - Cancers, 2022 - mdpi.com
Simple Summary Pancreatic ductal adenocarcinoma is a leading cause of cancer death worldwide. Due to the frequently late diagnosis, early metastasis and high therapy …